Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $3.96 on revenue of $2.77B. Analysts polled by Investing.com anticipated EPS of $2.71 on revenue of $2.43B.
Quest Diagnostics shares are up 6.14% from the beginning of the year, still down 8.54% from its 52 week high of $160.56 set on September 9. They are under-performing the S&P 500 which is up 20.77% from the start of the year.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.36 on revenue of $23.66B.
Abbott Labs had beat expectations on Wednesday with third quarter EPS of $1.4 on revenue of $10.93B, compared to forecast for EPS of $0.9442 on revenue of $9.55B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar